Stephen J Schuster

Stephen J Schuster

UNVERIFIED PROFILE

Are you Stephen J Schuster?   Register this Author

Register author
Stephen J Schuster

Stephen J Schuster

Publications by authors named "Stephen J Schuster"

Are you Stephen J Schuster?   Register this Author

100Publications

3105Reads

44Profile Views

Dynamic Changes in Gene Mutational Landscape With Preservation of Core Mutations in Mantle Cell Lymphoma Cells.

Front Oncol 2019 3;9:568. Epub 2019 Jul 3.

Department of Pathology and Laboratory Medicine, Abramson Cancer Center, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, PA, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2019.00568DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617136PMC
July 2019

Tisagenlecleucel in Diffuse Large B-Cell Lymphoma. Reply.

N Engl J Med 2019 04;380(16):1586

University of Pennsylvania, Philadelphia, PA

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMc1901464
Publisher Site
http://dx.doi.org/10.1056/NEJMc1901464DOI Listing
April 2019

Bexarotene in Patients With Peripheral T-cell Lymphomas: Results of a Retrospective Study.

Clin Lymphoma Myeloma Leuk 2019 Feb 13;19(2):109-115. Epub 2018 Oct 13.

Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S21522650183047
Publisher Site
http://dx.doi.org/10.1016/j.clml.2018.10.001DOI Listing
February 2019

Disease quantification on PET/CT images without explicit object delineation.

Med Image Anal 2019 01 10;51:169-183. Epub 2018 Nov 10.

Medical Image Processing group, Department of Radiology, 3710 Hamilton Walk, Goddard Building, 6th Floor, Philadelphia, PA 19104, United States; Abramson Cancer Center, Perelman Center for Advanced Medicine, University of Pennsylvania, Philadelphia, PA 19104, United States.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S13618415183055
Publisher Site
http://dx.doi.org/10.1016/j.media.2018.11.002DOI Listing
January 2019

Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma.

N Engl J Med 2019 01 1;380(1):45-56. Epub 2018 Dec 1.

From the Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia (S.J.S.); the Hematopoietic Cellular Therapy Program, University of Chicago Medicine, Chicago (M.R.B.); Peter MacCallum Cancer Centre, St. Vincent's Hospital and University of Melbourne, Melbourne, VIC (C.S.T.), and the Royal Prince Alfred Hospital and Department of Medicine, University of Sydney, Sydney (P.J.H.) - both in Australia; Winship Cancer Institute of Emory University, Bone Marrow and Stem Cell Transplant Center, Atlanta (E.K.W.); the Department of Hematology and Oncology, University Hospital of Cologne, Cologne (P.B.), and the Würzburg University Medical Center, Center for Allogeneic Stem Cell Transplantation, Würzburg (S.M.) - both in Germany; the Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Cancer Center, Kansas City (J.P.M.); the Department of Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna (U.J.); James Cancer Hospital and Solove Research Institute, Ohio State University Comprehensive Cancer Center, Columbus (S.J.); the Department of Hematology and Blood and Marrow Transplant, University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco (C.A.); the Department of Lymphoma and Myeloma, Division of Cancer Medicine, University of Texas M.D. Anderson Cancer Center, Houston (J.R.W.); Maisonneuve-Rosemont Hospital, University of Montreal, Montreal (I.F.), and the Juravinski Hospital and Cancer Centre, McMaster University, Hamilton, ON (S.R.F.) - both in Canada; the Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis (V.B.); Karolinska Institutet and University Hospital, Department of Laboratory Medicine/Department of Cell Therapy and Allogeneic Stem Cell Transplantation, Stockholm (S.M.); University of Michigan Comprehensive Cancer Center, Ann Arbor (J.M.M.); the Department of Oncology, Oslo University Hospital, Oslo (H.H.); Novartis Pharma, Basel, Switzerland (S.P., O.A.); Novartis Pharmaceuticals (L.B.P., J.C.) and Novartis Institutes for BioMedical Research (R.A.), East Hanover, NJ; the Department of Hematology, Hospices Civils de Lyon, Université de Lyon, Lyon, France (G.S.); and the Center for Hematologic Malignancies, Oregon Health and Science University Knight Cancer Institute, Portland (R.T.M.).

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1804980
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1804980DOI Listing
January 2019

CD19-directed CAR T cells gain traction.

Lancet Oncol 2019 Jan 2;20(1):2-3. Epub 2018 Dec 2.

Lymphoma Program, Abramson Cancer Center of the University of Pennsylvania, Perelman Center for Advanced Medicine, 34th and Civic Center Blvd, Philadelphia, PA 19104, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(18)30900-8DOI Listing
January 2019

Early positron emission tomography/computed tomography as a predictor of response after CTL019 chimeric antigen receptor -T-cell therapy in B-cell non-Hodgkin lymphomas.

Cytotherapy 2018 12 29;20(12):1415-1418. Epub 2018 Oct 29.

Lymphoma Program at the Abramson Cancer Center and the Division of Hematology-Oncology Perelman School of Medicine, University of Pennsylvania, Pennsylvania, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S14653249183063
Publisher Site
http://dx.doi.org/10.1016/j.jcyt.2018.10.003DOI Listing
December 2018

Rare case of low-grade extranodal NK/T-cell lymphoma, nasal type, arising in the setting of chronic rhinosinusitis and harboring a novel N-terminal KIT mutation.

Diagn Pathol 2018 Nov 23;13(1):92. Epub 2018 Nov 23.

Department of Pathology and Laboratory Medicine, Division of Hematopathology, Hospital of the University of Pennsylvania, 7.018 Gates Pavilion, 3400 Spruce Street, Philadelphia, PA, 19104-4283, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13000-018-0765-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6260989PMC
November 2018

Interim PET/CT Result Is Not Predictive of Survival in Patients With MYC-rearranged Non-Burkitt Aggressive B-cell Lymphoma.

Clin Lymphoma Myeloma Leuk 2018 10 15;18(10):673-678. Epub 2018 Jun 15.

Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2018.06.012DOI Listing
October 2018

Ibrutinib as Treatment for Patients With Relapsed/Refractory Follicular Lymphoma: Results From the Open-Label, Multicenter, Phase II DAWN Study.

J Clin Oncol 2018 08 31;36(23):2405-2412. Epub 2018 May 31.

Ajay K. Gopal, The University of Washington; Ajay K. Gopal, Fred Hutchinson Cancer Research Center, Seattle, WA; Stephen J. Schuster, Abramson Cancer Center of the University of Pennsylvania, Philadelphia; Jing-Zhou Hou, University of Pittsburgh Medical Center; Jing-Zhou Hou, University of Pittsburgh Cancer Institute, Pittsburgh; Rajendra N. Damle, Michael Schaffer, and Sriram Balasubramanian, Janssen Research & Development, Spring House, PA; Nathan H. Fowler, The University of Texas MD Anderson Cancer Center, Houston, TX; Judith Trotman, Concord Hospital, University of Sydney, Sydney, New South Wales; Andrew Spencer, Alfred Hospital-Monash University, Melbourne, Victoria; James Morton, Haematology and Oncology Clinics of Australia, Milton, Queensland, Australia; Georg Hess, Johannes Gutenberg-University, Mainz, Germany; Abdulraheem Yacoub, Kansas University Medical Center, Kansas City, KS; Michael Lill, Cedars-Sinai Medical Center, Los Angeles, CA; Peter Martin, Weill Cornell Medical College, Cornell University, New York, NY; Umberto Vitolo, Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino, Turin, Italy; John Radford, University of Manchester; John Radford, Christie National Health Service Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom; Wojciech Jurczak, Jagiellonian University, Kraków, Poland; Dolores Caballero, Hospital Clínico Universitario, Salamanca, Spain; Sanjay Deshpande, Gary J. Gartenberg, and Shean-Sheng Wang, Janssen Research & Development, Raritan, NJ; Jessica Vermeulen, Janssen Research & Development, Leiden, the Netherlands; Bruce D. Cheson, Georgetown University Hospital, Washington, DC; and Gilles Salles, Hospices Civils de Lyon-Université de Lyon, Pierre-Bénite cedex, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.76.8853DOI Listing
August 2018

The changing face of adult posttransplant lymphoproliferative disorder: Changes in histology between 1999 and 2013.

Am J Hematol 2018 07 6;93(7):874-881. Epub 2018 May 6.

Section of Hematology, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25116DOI Listing
July 2018

Comparable outcomes in chronic lymphocytic leukaemia (CLL) patients treated with reduced-dose ibrutinib: results from a multi-centre study.

Br J Haematol 2018 04 21;181(2):259-261. Epub 2017 Feb 21.

Center for CLL, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14540DOI Listing
April 2018

Spontaneous remission of acute myeloid leukemia after discontinuation of lenalidomide.

Leuk Lymphoma 2018 03 11;59(3):743-745. Epub 2017 Jul 11.

a Department of Medicine , Hospital of the University of Pennsylvania , Philadelphia , PA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2017.1347652DOI Listing
March 2018

Utilization of next generation sequencing identifies potentially actionable mutations in chronic lymphocytic leukaemia.

Br J Haematol 2018 01 7;180(2):299-301. Epub 2016 Oct 7.

Center for CLL, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14315DOI Listing
January 2018

Chimeric Antigen Receptor T-Cell Therapy for Chronic Lymphocytic Leukemia: A Narrative Review.

Clin Lymphoma Myeloma Leuk 2017 Dec 21;17(12):852-856. Epub 2017 Jul 21.

Center for Chronic Lymphocytic Leukemia, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S21522650173095
Publisher Site
http://dx.doi.org/10.1016/j.clml.2017.07.007DOI Listing
December 2017

Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas.

N Engl J Med 2017 12 10;377(26):2545-2554. Epub 2017 Dec 10.

From the Lymphoma Program at the Abramson Cancer Center and the Division of Hematology-Oncology (S.J.S., J.S., E.A.C., S.D.N., A.R.M., D.L., D.L.P.), and the Department of Pathology and Laboratory Medicine (V.B., M.W., B.L.L., S.F.L., J.J.M., C.H.J.), Perelman School of Medicine, University of Pennsylvania, Philadelphia; Novartis Pharmaceuticals, Basel, Switzerland (Ö.A.); and Novartis Institutes for BioMedical Research, Cambridge, MA (J.L.B., I.P-M.).

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1708566
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1708566DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5788566PMC
December 2017

Long-term outcomes of rituximab, temozolomide and high-dose methotrexate without consolidation therapy for lymphoma involving the CNS.

Int J Hematol Oncol 2017 Dec 26;6(4):113-121. Epub 2018 Jan 26.

Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Perelman Center for Advanced Medicine, 3400 Civic Center Blvd, 2 West Pavilion, Philadelphia, PA 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/ijh-2017-0020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6171986PMC
December 2017

Primary diffuse large B-cell lymphoma of the CNS: a rare case of spontaneous remission.

Int J Hematol Oncol 2017 Nov 20;6(3):69-73. Epub 2017 Nov 20.

Abramson Cancer Center, Hospital of the University of Pennsylvania, 12 South PCAM, 3400 Civic Center Blvd, PA 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/ijh-2017-0009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6171994PMC
November 2017

Outcomes of patients with relapsed/refractory Hodgkin lymphoma progressing after autologous stem cell transplant in the current era of novel therapeutics: A retrospective analysis.

Am J Hematol 2017 Sep 9;92(9):879-884. Epub 2017 Jun 9.

Hospital of the University of Pennsylvania, Department of Medicine, Division of Hematology/Oncology, Perelman Center for Advanced Medicine, Philadelphia, Pennsylvania, 19104.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24792DOI Listing
September 2017

PD-1 blockade modulates chimeric antigen receptor (CAR)-modified T cells: refueling the CAR.

Blood 2017 02 28;129(8):1039-1041. Epub 2016 Dec 28.

Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA; and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2016-09-738245DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5391777PMC
February 2017

Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study.

J Clin Oncol 2016 08 6;34(23):2698-704. Epub 2016 Jun 6.

Alexander M. Lesokhin and Deepika Cattry, Memorial Sloan Kettering Cancer Center; Alexander M. Lesokhin, Weill Cornell Medical College, New York, NY; Stephen M. Ansell, Mayo Clinic, Rochester, MN; Philippe Armand, Bjoern Chapuy, Gordon J. Freeman, Scott J. Rodig, and Margaret A. Shipp, Dana-Farber Cancer Institute; David Avigan, Beth Israel Deaconess Medical Center; Azra H. Ligon and Scott J. Rodig, Brigham and Women's Hospital, Boston, MA; Emma C. Scott, Oregon Health & Science University Knight Cancer Institute, Portland, OR; Ahmad Halwani, University of Utah Huntsman Cancer Institute, Salt Lake City, UT; Martin Gutierrez, Hackensack University Medical Center, Hackensack; Lili Zhu, Joseph F. Grosso, and M. Brigid Bradley Garelik, Bristol-Myers Squibb, Princeton, NJ; Michael M. Millenson, Fox Chase Cancer Center; Adam D. Cohen and Stephen J. Schuster, University of Pennsylvania, Philadelphia, PA; Daniel Lebovic, University of Michigan, Ann Arbor, MI; Madhav Dhodapkar, Yale Cancer Center, New Haven, CT; Ivan Borrello, Johns Hopkins University School of Medicine, Baltimore, MD; and John Timmerman, University of California, Los Angeles, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.65.9789DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5019749PMC
August 2016

Autologous stem cell transplantation in first complete remission may not extend progression-free survival in patients with peripheral T cell lymphomas.

Am J Hematol 2016 07 24;91(7):672-6. Epub 2016 Apr 24.

Abramson Cancer Center and the Division of Hematology and Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24372DOI Listing
July 2016

Who Should Be Tested for Double-Hit Lymphoma?

J Oncol Pract 2016 Mar;12(3):243-4

University of Pennsylvania, Philadelphia, PA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2015.010595DOI Listing
March 2016

Lenalidomide plus Rituximab as Initial Treatment for Mantle-Cell Lymphoma.

N Engl J Med 2015 Nov;373(19):1835-44

From the Meyer Cancer Center, Division of Hematology and Medical Oncology (J.R., P.M., R.R.F., A.R., J.L., O.K., M.C., J.P.L.), and Division of Biostatistics and Epidemiology (P.C.), Weill Cornell Medical College and New York-Presbyterian Hospital, New York; Moffitt Cancer Center, Tampa, FL (B.S.); University of Pennsylvania Abramson Cancer Center, Philadelphia (S.J.S., J.S.); and the University of Chicago Medical Center, Chicago (S.M.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1505237DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4710541PMC
November 2015

Outpatient Autologous Stem Cell Transplantation for Patients With Myeloma.

Clin Lymphoma Myeloma Leuk 2015 Sep 6;15(9):536-40. Epub 2015 Jun 6.

Hematologic Malignancies and Bone Marrow Transplant Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2015.05.006DOI Listing
September 2015

Front-line, dose-escalated immunochemotherapy is associated with a significant progression-free survival advantage in patients with double-hit lymphomas: a systematic review and meta-analysis.

Br J Haematol 2015 Aug 24;170(4):504-14. Epub 2015 Apr 24.

Center for Chronic Lymphocytic Leukemia and Lymphoma Program, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/bjh.13463
Publisher Site
http://dx.doi.org/10.1111/bjh.13463DOI Listing
August 2015

Management of chronic lymphocytic leukemia (CLL) in the era of B-cell receptor signal transduction inhibitors.

Am J Hematol 2015 Jul 28;90(7):657-64. Epub 2015 May 28.

Center for Chronic Lymphocytic Leukemia and Lymphoma Program, Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ajh.24021
Publisher Site
http://dx.doi.org/10.1002/ajh.24021DOI Listing
July 2015

Progressive multifocal leukoencephalopathy--a case report and review of the literature.

In Vivo 2014 Sep-Oct;28(5):941-8

Department of Neuropathology, Institute of Pathology, Medical University Graz, Graz, Austria

View Article

Download full-text PDF

Source
May 2015

Anxiety and health-related quality of life among patients with low-tumor burden non-Hodgkin lymphoma randomly assigned to two different rituximab dosing regimens: results from ECOG trial E4402 (RESORT).

J Clin Oncol 2015 Mar 20;33(7):740-8. Epub 2015 Jan 20.

Lynne I. Wagner and David Cella, Northwestern University Feinberg School of Medicine, Chicago, IL; Fengmin Zhao, Fangxin Hong, Dana-Farber Cancer Institute, Boston, MA; Michael E. Williams, University of Virginia, Charlottesville, VA; John C. Krauss, University of Michigan, Ann Arbor, MI; Ranjana H. Advani, Stanford University, Stanford; Sandra J. Horning, Genentech, South San Francisco, CA; Ronald S. Go, Gunderson Health System, La Crosse; Brad S. Kahl, University of Wisconsin, Madison, WI; Thomas M. Habermann, Mayo Clinic, Rochester; Joseph W. Leach, Metro Minnesota Community Clinical Oncology Program, Minneapolis, MN; Brian O'Connor, Frederick Memorial Health System, Frederick, MD; Stephen J. Schuster, University of Pennsylvania, Philadelphia, PA; and Randy D. Gascoyne, British Columbia Cancer Agency, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/33/7/740.full.pdf
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2014.57.6801
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.57.6801DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4334777PMC
March 2015

R-CHOP or R-HyperCVAD with or without autologous stem cell transplantation for older patients with mantle cell lymphoma.

Clin Lymphoma Myeloma Leuk 2015 Feb 1;15(2):92-7. Epub 2014 Aug 1.

Division of Hematology and Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2014.07.017DOI Listing
February 2015

The role of FDG-PET imaging as a prognostic marker of outcome in primary mediastinal B-cell lymphoma.

Cancer Med 2015 Jan 10;4(1):7-15. Epub 2014 Sep 10.

Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cam4.322DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4312112PMC
January 2015

PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma.

N Engl J Med 2015 Jan 6;372(4):311-9. Epub 2014 Dec 6.

From the Mayo Clinic, Rochester, MN (S.M.A.); Memorial Sloan Kettering Cancer Center (A.M.L., D.C.) and Weill Cornell Medical College (A.M.L.) - both in New York; Johns Hopkins University School of Medicine and the Sidney Kimmel Comprehensive Cancer Center, Baltimore (I.B.); University of Utah Huntsman Cancer Institute, Salt Lake City (A.H.); Oregon Health and Science University and the Knight Cancer Institute, Portland (E.C.S.); John Theurer Cancer Center, Hackensack University Medical Center, Hackensack (M.G.), and Bristol-Myers Squibb, Lawrenceville (L.Z., J.F.G., S.Y.K.) - both in New Jersey; Abramson Cancer Center, University of Pennsylvania (S.J.S.), and Fox Chase Cancer Center (M.M.M.) - both in Philadelphia; Dana-Farber Cancer Institute (G.J.F., B.C., M.A.S., P.A.) Brigham and Women's Hospital (S.J.R., A.H.L.), and Harvard Medical School (G.J.F., B.C., M.A.S., P.A., S.J.R., A.H.L.) - all in Boston; and Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles (J.M.T.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1411087DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4348009PMC
January 2015

Rituximab extended schedule or re-treatment trial for low-tumor burden follicular lymphoma: eastern cooperative oncology group protocol e4402.

J Clin Oncol 2014 Oct 25;32(28):3096-102. Epub 2014 Aug 25.

Brad S. Kahl, University of Wisconsin, Madison; Christopher G. Peterson, Aspirus Regional Cancer Center, Wausau; Matthias Weiss, Marshfield Clinic, Marshfield, WI; Fangxin Hong, Dana-Farber Cancer Institute, Boston, MA; Michael E. Williams, University of Virginia, Charlottesville, VA; Randy D. Gascoyne, British Columbia Cancer Agency, Vancouver, British Columbia, Canada; Lynne I. Wagner, Northwestern University, Chicago, IL; John C. Krauss, University of Michigan, Ann Arbor, MI; Thomas M. Habermann, Mayo Clinic, Rochester; Mark D. Sborov, Fairview-Southdale Hospital, St Louis Park, MN; Lode J. Swinnen, Johns Hopkins University, Baltimore, MD; Stephen J. Schuster, University of Pennsylvania, Philadelphia; W. Christopher Ehmann, Penn State Cancer Institute, Hershey, PA; S. Eric Martin, Christiana Care Community Clinical Oncology Program and Helen F. Graham Cancer Network, Newark, DE; and Sandra J. Horning, Genentech, South San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.56.5853DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171355PMC
October 2014

'Double-Hit' cytogenetic status may not be predicted by baseline clinicopathological characteristics and is highly associated with overall survival in B cell lymphoma patients.

Br J Haematol 2014 Aug 25;166(3):369-74. Epub 2014 Apr 25.

Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.12901DOI Listing
August 2014

Could treatment with R-HCVAD/R-MA as compared to R-CHOP truly result in improved outcomes for patients with high-risk diffuse large B cell lymphoma?

Br J Haematol 2014 Apr 19;165(1):145-6. Epub 2013 Dec 19.

Hematologic Malignancies Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.12702DOI Listing
April 2014

Combined lenalidomide, low-dose dexamethasone, and rituximab achieves durable responses in rituximab-resistant indolent and mantle cell lymphomas.

Cancer 2014 Jan 7;120(2):222-8. Epub 2013 Oct 7.

Lymphoma Program, Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.28405DOI Listing
January 2014

Outcomes of patients with relapsed/refractory diffuse large B-cell lymphoma with progression of lymphoma after autologous stem cell transplantation in the rituximab era.

Am J Hematol 2013 Oct 1;88(10):890-4. Epub 2013 Aug 1.

Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ajh.23524
Publisher Site
http://dx.doi.org/10.1002/ajh.23524DOI Listing
October 2013

Plasmacytic post-transplant lymphoproliferative disorder: a case series of nine patients.

Transpl Int 2013 Jun 28;26(6):616-22. Epub 2013 Mar 28.

Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/tri.12091DOI Listing
June 2013

Post-transplant lymphoproliferative disorder after lung transplantation: a review of 35 cases.

J Heart Lung Transplant 2012 Mar 23;31(3):296-304. Epub 2011 Nov 23.

Abramson Cancer Center, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.healun.2011.10.013DOI Listing
March 2012

The Evolving Role of Medical Imaging in Lymphoma Management: The Clinician's Perspective.

PET Clin 2012 Jan;7(1):35-46

Division of Hematology/Oncology, Department of Medicine, The University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cpet.2011.12.004DOI Listing
January 2012

PET Imaging of Lymphoma.

PET Clin 2012 Jan;7(1):xiii

Division of Hematology/Oncology, Department of Medicine, The University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cpet.2012.01.001DOI Listing
January 2012

NMR metabolic and physiological markers of therapeutic response.

Adv Exp Med Biol 2011 ;701:129-35

Laboratory of Molecular Imaging, Department of Radiology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-4419-7756-4_18DOI Listing
August 2011

Myocarditis during lenalidomide therapy.

Ann Pharmacother 2010 Nov 28;44(11):1840-3. Epub 2010 Sep 28.

Abramson Cancer Center, Heart and Vascular Institute, University of Pennsylvania, Philadelphia, USA.

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.1345/aph.1P044
Publisher Site
http://dx.doi.org/10.1345/aph.1P044DOI Listing
November 2010

Rituximab and statins.

J Clin Oncol 2010 Oct 30;28(30):e611; author reply e612. Epub 2010 Aug 30.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2010.30.0418DOI Listing
October 2010

Detection of Epstein-Barr virus in T-cell prolymphocytic leukemia cells in vitro.

J Clin Virol 2008 Nov 14;43(3):260-5. Epub 2008 Sep 14.

Department of Microbiology and the Tumor Virology Program of Abramson Comprehensive Cancer Center, University of Pennsylvania Medical School, 201E Johnson Pavilion, Philadelphia, PA 19104, U S.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcv.2008.07.018DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4289600PMC
November 2008

Durable complete responses from therapy with combined epratuzumab and rituximab: final results from an international multicenter, phase 2 study in recurrent, indolent, non-Hodgkin lymphoma.

Cancer 2008 Nov;113(10):2714-23

Center for Lymphoma and Myeloma, Division of Hematology/Oncology, Weill Cornell Medical College and New York Presbyterian Hospital, New York, New York, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.23890
Publisher Site
http://dx.doi.org/10.1002/cncr.23890DOI Listing
November 2008

Marginal zone lymphoma involving subcutaneous fat: appearance by FDG-PET/CT, MRI, and contrast-enhanced CT imaging.

Clin Nucl Med 2008 Oct;33(10):692-3

Division of Hematology/Oncology, Abramson Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RLU.0b013e318184b407DOI Listing
October 2008

Successful treatment of relapsed lymphomatoid granulomatosis with bexarotene.

Cancer Biol Ther 2008 Oct 21;7(10):1544-6. Epub 2008 Oct 21.

Abramson Cancer Center, Hospital of the University of Pennsylvania, University of Pennsylvania, Philadelphia, PA 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/cbt.7.10.6834DOI Listing
October 2008

GM-CSF plus rituximab immunotherapy: translation of biologic mechanisms into therapy for indolent B-cell lymphomas.

Leuk Lymphoma 2008 Sep;49(9):1681-92

Department of Medicine, Hematology-Oncology Division, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190802216731DOI Listing
September 2008

Commentary: let the tail wag the dog: the case for radioimmunotherapy of low-grade follicular lymphoma.

Oncologist 2008 Jun;13(6):655-6

Department of Radiation Oncology, Hospital of the University of Pennsylvania, 2 Donner Building, 3400 Spruce Street, Philadelphia, PA 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2008-0113DOI Listing
June 2008

Primary cardiac lymphoma: utility of multimodality imaging in diagnosis and management.

Cancer Biol Ther 2007 Dec 13;6(12):1867-70. Epub 2007 Oct 13.

Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/cbt.6.12.5166DOI Listing
December 2007

Primary lymphomas of the cervix and uterus: the University of Pennsylvania's experience and a review of the literature.

Leuk Lymphoma 2006 Sep;47(9):1894-901

Abramson Cancer Center of the Hospital of the University of Pennsylvania, 3400 Spruce, Philadelphia, PA 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190600687653DOI Listing
September 2006